Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Gemcitabine
×
90 days
×
Clear all
Filters
3
NCT06841354
2026-03-13
TroFuse-011
Merck Sharp & Dohme LLC
Phase 3
Recruiting
1,000 enrolled
NCT06623422
2026-03-11
INTerpath-009
Merck Sharp & Dohme LLC
Phase 3
Recruiting
680 enrolled
NCT06788912
2026-03-10
MK-3475-01E
Merck Sharp & Dohme LLC
Phase 2
Recruiting
60 enrolled
NCT04191135
2026-03-03
KEYLYNK-009
Merck Sharp & Dohme LLC
Phase 2
Completed
462 enrolled
30 charts
NCT04700124
2026-02-05
KEYNOTE-B15
Merck Sharp & Dohme LLC
Phase 3
Completed
808 enrolled